NCT00438152View on ClinicalTrials.gov

Lopinavir Capsules to Kaletra or Invirase Tablets

PHASE4CompletedINTERVENTIONAL
Enrollment

53

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

February 28, 2009

Study Completion Date

February 28, 2009

Conditions
HIV Infections
Interventions
DRUG

Saquinavir (Invirase®)

Saquinavir 1000mg + Ritonavir 100mg Bd for 24 weeks

DRUG

Lopinavir/ritonavir (Kaletra®)

Lopinavir/ritonavir 400/100 mg BD 24 weeks

Trial Locations (1)

NW32QG

Royal Free Hampstead NHS Trust, London

All Listed Sponsors
collaborator

Roche Pharma AG

INDUSTRY

lead

Royal Free Hampstead NHS Trust

OTHER

NCT00438152 - Lopinavir Capsules to Kaletra or Invirase Tablets | Biotech Hunter | Biotech Hunter